Author Archives: admin

NOAH-AFNET 6 Trial: Edoxaban in AHRE

The NOAH-AFNET 6 trial, as outlined in a groundbreaking study from the New England Journal of Medicine in 2023, represents a significant advancement in our understanding of atrial fibrillation management. This study scrutinized the efficacy of edoxaban, a novel oral … Read More

SELECT Trial: Semaglutide and CV outcomes

Semaglutide Improve CV events? SELECT Trial Summary The SELECT trial, a pivotal study published in the New England Journal of Medicine (NEJM) in November 2023, has offered the medical community valuable insights into the treatment of cardiovascular (CV) events in … Read More

DUPLEX Trial: Sparsentan in FSGS

The DUPLEX Trial: Evaluating Kidney Protection in FSGS Patients The DUPLEX trial, a rigorous study published in the New England Journal of Medicine in 2023, has garnered significant attention in the nephrology community. The trial investigated the long-term nephroprotective potential … Read More

ORBITA-2 Trial: PCI in Stable Angina

Understanding the Impact of PCI in Stable Angina: Insights from the ORBITA-2 Trial The ORBITA-2 trial has emerged as a cornerstone study in the field of cardiology, particularly in the treatment of stable angina through Percutaneous Coronary Intervention (PCI). This … Read More

ACT HIV Trial: Dexamethasone in TB Meningitis

ACT HIV TRIAL (2023) Summary and Key Points In 2023, a significant study titled the “ACT HIV TRIAL” was published, which delved into the potential benefits of using adjunctive dexamethasone for the treatment of tuberculous meningitis in HIV-positive adults. This … Read More

ASAP Trial: Vancomycin and Cefazolin in Arthroplasty Prophylaxis

The ASAP Trial: Vancomycin and Cefazolin in Arthroplasty Prophylaxis – An Analysis The realm of surgical prophylaxis has always been a topic of deep medical interest, aiming to prevent complications and ensure the best outcomes for patients. One such endeavor … Read More

NSCLC Treatment: The AEGEAN Trial Breakthrough

“Innovations in NSCLC Treatment: The AEGEAN Trial Breakthrough” In recent years, the pursuit of more effective treatments for non-small-cell lung cancer (NSCLC) has been relentless. The AEGEAN trial of 2023, as reported in the esteemed New England Journal of Medicine … Read More

T-PASS Trial: A Shift in Post-Stenting Treatment for ACS

T-PASS Trial Summary The management of Acute Coronary Syndrome (ACS) after stenting has been a hot topic for medical researchers for years. The recent T-PASS Trial in 2023 has shed light on the possible advantages of shifting from the conventional … Read More

AMIKINHAL Trial: Inhaled Amikacin in Preventing VAP

The medical world is continually seeking innovative methods to combat and prevent life-threatening conditions. One such condition is ventilator-associated pneumonia, a severe complication that affects patients undergoing mechanical ventilation. The recent AMIKINHAL trial, a multicenter, double-blind, randomized, controlled, superiority study, … Read More

VIOLET Trial: High-Dose Vitamin D3 for Critically Ill

VIOLET Trial Summary The VIOLET trial was a phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the effects of early vitamin D3 supplementation in critically ill patients with vitamin D deficiency who were at high risk for death. Vitamin … Read More